Hao Wu, Ph.D.Scientist 4, Peptide Therapeutics at GenentechSpeaker
Profile
Dr. Hao Wu is currently Scientist 4 at Genentech, Departments of Early Discovery Biochemistry, Peptide Therapeutics Division. He has been involved in many projects to improve the drug-like properties of peptides, using rational design, structure-guided design, and combinatorial chemistry approach. Before joining Genentech, Dr. Wu had postdoctoral training at The Scripps Research Institute – Florida using peptidomimetics targeting intracellular targets, and obtained his Ph.D. in Department of Chemistry, National University of Singapore, training in organic chemistry, developed small molecule microarray platform for PPI inhibitor discovery.
Agenda Sessions
Potency-enhanced Peptidomimetic VHL Ligands with Improved Oral Bioavailability
, 3:00pmView Session